Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Laboratoires Pierre Fabre S.A.
DescriptionN-hexane lipidosterolic extract of Serenoa repens
Molecular Target 5-alpha reductase
Mechanism of Action5-alpha reductase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationBenign prostatic hyperplasia (BPH)
Indication DetailsBenign prostatic hyperplasia (BPH)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today